Inventor · disambiguated record
Peng-Cheng Lu
Also filed as: LU PENG · Lu peng-cheng
13 granted patents·15 pending applications·27 citations·filing 2012–2025
89Inventor score
Files withBIOCRYST PHARM INC12CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3UNIV JOHNS HOPKINS3BEIJING TIDE PHARMACEUTICAL CO LTD1BEIJING TIDE PHARMACEUTICAQL CO LTD1
Top patents by PatentIndex Score
28 records- 0195US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 0295US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 0394US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 0493US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 0591US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 0688US11597716B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 7, 2023·5 cites·20 claims
- 0787US9399660B2N-substituted indenoisoquinolines and syntheses thereofPURDUE RESEARCH FOUNDATION·Filed 2015·Granted Jul 26, 2016·4 cites·20 claims
- 0886US11661426B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2018·Granted May 30, 2023·2 cites·42 claims
- 0986US2024294494A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 1079US2024376117A1Imidazole-containing inhibitors of alk2 kinaseBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 1177US12054492B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2023·Granted Aug 6, 2024·0 cites·37 claims
- 1277US11458141B2Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Oct 4, 2022·1 cites·9 claims
- 1371US12116356B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Granted Oct 15, 2024·0 cites·20 claims
- 1467US2024367997A1Multi-element co-doped sodium-ion positive electrode material, and preparation method therefor and use thereofSHANGHAI ENERGY NEW MATERIAL TECH CO/ LTD·Filed 2024·Application pending·0 cites
- 1565US2024293559A1SHP2 inhibitor, pharmaceutical composition containing the same and application thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1663US2024316207A1Shp2 inhibitor, pharmaceutical composition comprising same and application thereofBEIJING TIDE PHARMACEUTICAQL CO LTD·Filed 2024·Application pending·0 cites
- 1757US2024239752A1Bicyclic heteroaromatic inhibitors of klk5BIOCRYST PHARM INC·Filed 2022·Application pending·0 cites
- 1855US2024270750A1Imidazole-containing inhibitors of alk2 kinaseBIOCRYST PHARM INC·Filed 2022·Application pending·0 cites
- 1955US2023104754A1Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attackTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2052US12240811B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 4, 2025·0 cites·4 claims
- 2152US2025154188A1C-glycosides as anti-inflammatory agentsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2025·Application pending·0 cites
- 2251US2025275991A1Oral complement factor d inhibitorsBIOCRYST PHARM INC·Filed 2020·Application pending·0 cites
- 2351US2023357261A1Aryl hydrocarbon receptor ligands and their analogues for the prevention and treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2451US2020109214A1Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attackDYAX CORP·Filed 2019·Application pending·0 cites
- 2549US2023338358A1Prophylaxis and treatment of angioedemaPHARVARIS GMBH·Filed 2021·Application pending·0 cites
- 2648US2022079935A1Compounds and treatments that enhance enteric nervous system functionUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2748US2021032139A1Regulating a microenvironment of anaerobic granular sludge to promote anaerobic digestion and delay calcificationUNIV GUANGXI·Filed 2020·Application pending·0 cites
- 2832US8785477B2Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereofLU PENG·Filed 2012·Granted Jul 22, 2014·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Peng-Cheng Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →